ArticlePloS one2012

Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cells.

Eric Bartee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.